A post-hoc analysis from the ReFlaP study showed that there was a significant correlation between PsAID12 & HAQ scor https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg […]
CHICAGO — Medical board-style questions created by AI and large language models were often grammatically correct but factually inaccurate, according
… Rheumatology (ACR) Convergence 2025. To better understand the impact of NSAID use in this patient population, researchers used claims
#0852 LEVI-04, a novel p75NTR-Fc fusion protein, significantly reduces MRI bone marrow lesions in knee #OA 🦵📉 Phas https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg john+RNV2@john…
@JYazdanyMD in the #ACR25 Great AI Debate details out three key risks of AI in rheumatology: – bias at scale
In this ph2 trial of LEVI-04 for knee #osteoarthritis, At wk 20, LEVI-04 ⬇️ bone marrow lesions (BML), greater ⬇
Summary take home points by Dr Highland 1. PAH and PH-ILD are associated with high mortality in patients with SARDs
In the #ACR25 Great AI Debate, @RADoctor and @JYazdanyMD prepared independently, but in consecutive moments agree (in a https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4_normal.jpg john+RNV2@john…
The CLASSIC study (n=1015, 27 countries) validated revised ASAS-SPARTAN axSpA criteria. Final model achieved 79.5% sensi https://pbs.twimg.com/profile_images/926606033270665216/Z42VohYE_normal.jpg john+RNV2@john… Mon, 10/27/2025
#0853 Olink proteomics in anti-Ro+ pregnancies identifies macrophage-derived IL-6 & CCL3 as serum predictors of foet https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg john+RNV2@john… Mon, 10/27/2025
#1627 SLR informing the 2025 @eular_org recommendations for PMR & LVV 🔍 141 studies (30 RCTs) reviewed: new & https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg
#0854 @Official_ASAS & @SPARTAN_Updates revised #axSpA criteria meet targets: Sn 79.5% / Sp 90.4%. Imaging is centr https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg john+RNV2@john… Mon,
Summary of (some) drugs in the pipeline for management of PAH. Slide credits: Dr Benjamin Freed @RheumNow #ACR2025 https://pbs.twimg.com/profile_images/1798008672708169728/8cvULQ3I_normal.jpg john+RNV2@john…
Clinical and Medicare records for more than 40,000 patients seen at U.S. rheumatology clinics in 2021 showed that 43.3% received
(MedPage Today) — CHICAGO — Urgent advice to prescribe alternatives to opioid painkillers doesn’t seem to be getting through to
The most common rheumatic disease reported was rheumatoid arthritis (58%), followed by Sjögren disease (19%). CAM usage was found to
… Rheumatology (ACR) Convergence 2025. A retrospective cohort study was conducted using data from the TriNetX Global Collaborative Network to …
I recently had the privilege of speaking at the Advances in Rheumatology and Technologies Symposium (ARTS), held in Chicago on
🎥 LIVE from #ACR25 Join us daily at 5 PM CST for RheumNow’s ACR Recap Live – Your must-watch debrief
Early Peripheral SpA: Is it okay to stop treatment sometimes? tammytilley@gm… Mon, 10/27/2025 – 09:52 Spondyloarthritis Dr. Richard Conway reports
In a global retrospective study of 90,536 PsA patients, those on GLP-1 receptor agonists (n=4,104) had significantly low https://pbs.twimg.com/profile_images/926606033270665216/Z42VohYE_normal.jpg john+RNV2@john…
Time for the 2nd plenary session! 🎤 #0849 GLP-1 receptor agonists in #PsA linked with lower mortality & fewer maj
This morning in the plenary, same theme, but in PsA: Similar metabolic/CV concerns Similarly benefit from GLP-1 RA look https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4_normal.jpg
GLP-1 RA meds: we are just starting to see their impact in rheumatoid arthritis. We know metabolic, CV risk in
Catching AxSpA Early: Closing the Diagnostic Gap tammytilley@gm… Mon, 10/27/2025 – 09:20 Spondyloarthritis Labs/Biomarkers Dr. Akhil Sood reports on abstract
Is Low Disease Activity Low Enough? tammytilley@gm… Mon, 10/27/2025 – 09:10 Rheumatoid Arthritis Drs. Jonathan Kay and Joel Kremer discuss
… Rheumatology Convergence, this year taking place in Chicago. Established in 2005, the Evelyn V. Hess Award recognizes a clinical
